Natural-killer cell activity and cytogenetic response in chronic myelogenous leukemia treated with alpha-interferon

Br J Haematol. 1991 Aug;78(4):585-6. doi: 10.1111/j.1365-2141.1991.tb04502.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child, Preschool
  • Cytotoxicity, Immunologic*
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Killer Cells, Natural / immunology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins